Evidence map›Paper›PMID 40452399›Full record

ArticleInterventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences2025

Chronic migraine and bilateral occlusion of the middle meningeal artery.

José Ricardo Vanzin, Luciano Bambini Manzato

Registry-linked trialAbstract read
In one paragraph

Article in Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07633067 (Safety and Efficacy of Middle Meningeal Artery Embolization for the Treatment of Migraine), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07633067 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Safety and Efficacy of Middle Meningeal Artery Embolization for the Treatment of Migraine: A Multicenter, Prospective, Double-blind, Multigroup, Randomized Controlled Trial.

TypeinterventionalSponsorThe Affiliated Hospital Of Guizhou Medical UniversityRan2026 to 2028Enrolled150ConditionsMigraineArmsMiddle meningeal artery embolization, Conventional standard pharmacotherapy for migraine
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

José Ricardo VanzinVascular Neurosurgeon and Interventional Neuroradiology of Neurology and Neurosurgery Service, Passo Fundo, Rio Grande do Sul, Brazil.ORCID 0000-0002-5100-5624
Luciano Bambini ManzatoVascular Neurosurgeon and Interventional Neuroradiology of Neurology and Neurosurgery Service, Passo Fundo, Rio Grande do Sul, Brazil.ORCID 0000-0002-4291-3831

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BackgroundMigraine is the most common neurological problem in primary care affecting 18% of women and 6% of men, while chronic migraine affects 2% of the population and refractory migraine is estimated to affect between 5% and 30% of migraine sufferers. The dura is a well-vascularized structure, which is densely innervated by pain fibers. Intra-arterial administration of lidocaine in the middle meningeal artery (MMA) has been used for refractory migraine, promoting pain relief. Patients with chronic headaches who underwent embolization of the MMA for the prevention of chronic subdural hematoma recurrence experienced complete resolution of pain.MethodsBased on this data, we treated 10 patients consecutively with chronic and refractory migraine with a high degree of disability assessed by headache impact test (HIT-6) who experimented with pain relief with lidocaine injection and subsequently underwent definitive bilateral occlusion of the MMA with biological glue.ResultsMean age was 48.2 ± 14.4, with 90% being female, all patients confirmed primary headache in the lidocaine suppression test (LST) and after bilateral occlusion was observed worsening of pain between 0 h and 6 h (-0.9 (95% CI -2.2-0.6,

Indexed as

biological glueChronic migraineintra-arterial lidocainemiddle meningeal arteryrefractory migraine

Identifiers

PMID40452399
PMCPMC12129948

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.